 | Agile Therapeutics, Inc. |
| 101 Poor Farm Road | |
| Princeton, NJ 08540 | |
| T: 609-683-1880 | |
| F: 609-683-1855 | |
| www.agiletherapeutics.com |
October 9, 2020
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jason L. Drory
Re: Agile Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-249273
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Agile Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-249273) (the “Registration Statement”), so that the Registration Statement may become effective at 4:00 p.m. (Washington, D.C. time) on October 14, 2020, or as soon as practicable thereafter.
| AGILE THERAPEUTICS, INC. | ||
| By: | /s/ Alfred Altomari | |
| Name: | Alfred Altomari | |
| Title: | Chairman and Chief Executive Officer | |